ZAP Surgical Systems completes first surgery by new ZAP-X Gyroscopic Radiosurgery Platform

02nd July, 2024

Designed to enhance precision and minimize potential radiation exposure to healthy critical anatomy

ZAP Surgical Systems announced the completion of the first patient treatments at Dongguk University Ilsan Hospital using the ZAP-X Gyroscopic Radiosurgery platform. This marks the second installation of the ZAP-X system in Korea, advancing the provision of cutting-edge medical care to patients in the Asia-Pacific region.

With the addition of the ZAP-X platform, the Neurosurgery department at Dongguk University Ilsan Hospital will now independently lead cranial SRS treatments. Stereotactic radiosurgery (SRS) provides a non-invasive and painless treatment option for treating many primary and metastatic brain tumors, as well as other conditions of the head and neck. With outcomes equivalent or superior to traditional open surgeries, SRS typically involves only one to five brief outpatient visits, allowing patients to often resume normal activities on the same day.

The ZAP-X system is exclusively optimized for cranial, head, and neck applications, helping to ensure the highest precision and minimize potential radiation exposure to healthy critical anatomy. The ZAP-X system's design utilizes gyroscopic mobility to precisely focus high-dose radiation on targeted tumors from thousands of potential angles, maximizing the preservation of healthy brain tissue and patient cognitive function. Further, its vault-free and cobalt-free features eliminate the requirement for expensive shielded radiation treatment rooms and the management of radioactive isotopes.

Dr. Seung-yeob Yang, Professor of Neurosurgery at Dongguk University Ilsan Hospital expressed his enthusiasm, stating, "The ZAP-X system represents a meaningful advancement in our ability to treat primary and metastatic brain tumors, as well as functional disorders such as trigeminal neuralgia. Its precision and non-invasive nature allow us to provide our patients with the best possible care while minimizing side effects and patient downtime." 

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer